Stemming a tumor with a little miR

Wicha, Max S.
February 2011
Nature Medicine;Feb2011, Vol. 17 Issue 2, p162
Academic Journal
The article reports on the ability of microRNA to decrease the expression of the adhesion molecule CD44 in prostate cancer stem cells (CSCs) in the U.S. It states that microRNA has also the ability to block tumor growth and metastasis. It notes that the systematic delivery of negative regulator may also open new avenues for targeting CSCs to halt cancer.


Related Articles

  • Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy. Chang, Lei; Graham, Peter; Hao, Jingli; Bucci, Joseph; Cozzi, Paul; Kearsley, John; Li, Yong // Cancer & Metastasis Reviews;Sep2014, Vol. 33 Issue 2/3, p469 

    Radiation therapy (RT) continues to be one of the most popular treatment options for localized prostate cancer (CaP). Local CaP recurrence after RT is a pattern of treatment failure attributable to radioresistance of cancer cells. One major obstacle to RT is that there is a limit to the amount...

  • Integrating new discoveries into the 'vicious cycle' paradigm of prostate to bone metastases. Cook, Leah; Shay, Gemma; Aruajo, Arturo; Lynch, Conor // Cancer & Metastasis Reviews;Sep2014, Vol. 33 Issue 2/3, p511 

    In prostate to bone metastases, the 'vicious cycle' paradigm has been traditionally used to illustrate how metastases manipulate the bone forming osteoblasts and resorbing osteoclasts in order to yield factors that facilitate growth and establishment. However, recent advances have illustrated...

  • Loss of Let-7 MicroRNA Upregulates IL-6 in Bone Marrow-Derived Mesenchymal Stem Cells Triggering a Reactive Stromal Response to Prostate Cancer. Sung, Shian-Ying; Liao, Chia-Hui; Wu, Hsun-Pai; Hsiao, Wan-Chi; Wu, I-Hui; Jinpu; Yu; Lin, Sue-Hwa; Hsieh, Chia-Ling // PLoS ONE;Aug2013, Vol. 8 Issue 8, p1 

    Bone marrow-derived mesenchymal stem cells (MSCs) are able to migrate to tumors, where they promote tumorigenesis and cancer metastasis. However, the molecular phenotype of the recruited MSCs at the tumor microenvironment and the genetic programs underlying their role in cancer progression...

  • Macrophage role in the anti-prostate cancer response to one class of antiangiogenic agents. Joseph, Ingrid B. J. K.; Isaacs, John T.; Joseph, I B; Isaacs, J T // JNCI: Journal of the National Cancer Institute;11/04/98, Vol. 90 Issue 21, p1648 

    Background: Tumor-associated macrophages (TAMs) can either promote angiogenesis (i.e., the formation of new blood vessels) in tumors by secreting tumor necrosis factor-alpha (TNF-alpha) or inhibit angiogenesis by producing granulocyte-macrophage colony-stimulating factor (GM-CSF),...

  • Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells. Yuan Lu; Jilong Li; Jianlin Cheng; Lubahn, Dennis B. // BMC Molecular Biology;12/1/2015, Vol. 16, p1 

    Background: Orphan nuclear receptor estrogen related receptor β (Esrrb or ERRβ) is well known in stem cells and early embryonic development. However, little is known about its function in cancer. Method: We investigated the mRNA profile alterations induced by Esrrb expression and its...

  • Getting Personal with Prostate Cancer: Adding New Pieces to an Incomplete Jigsaw Puzzle. Farooqi, Ammad A.; Bhatti, Shahzad // Urologia Internationalis;Sep2011, Vol. 87 Issue 2, p127 

    Prostate cancer is a multifaceted molecular anomaly that is insurmountable to date because of the orchestrated network of negative regulators that drive carcinogenesis. A substantial fraction of information has been added that gives yet an unclear snapshot of therapeutic interventions in...

  • TBK1 Regulates Prostate Cancer Dormancy through mTOR Inhibition. Jin Koo Kim; Younghun Jung; Jingcheng Wang; Joseph, Jeena; Mishra, Anjali; Hill, Elliott E.; Krebsbach, Paul H.; Pienta, Kenneth J.; Yusuke Shiozawa; Taichman, Russell S. // Neoplasia;Sep2013, Vol. 15 Issue 9, p1064 

    The mechanisms that regulate hematopoietic stem cell (HSC) dormancy and self-renewal are well established and are largely dependent on signals emanating from the HSC niche. Recently, we found that prostate cancer (PCa) cells target the HSC niche in mouse bone marrow (BM) during metastasis....

  • Pristimerin Inhibits Prostate Cancer Bone Metastasis by Targeting PC-3 Stem Cell Characteristics and VEGF-Induced Vasculogenesis of BM-EPCs. Huang, Shuai; He, Peiheng; Peng, Xinsheng; Li, Jinglei; Xu, Dongliang; Tang, Yubo // Cellular Physiology & Biochemistry (Karger AG);Aug2015, Vol. 37 Issue 1, p253 

    Background/Aims: Prostate cancer (PCa) is one of the most common malignant cancers and a major leading cause of cancer deaths in men. Cancer stem-like cells are shown to be highly tumorigenic, pro-angiogenic and can significantly contribute to tumor new vessel formation and bone marrow...

  • Prostate Cancer Restricted by Curcumin: Study.  // India -- West;10/26/2012, Vol. 37 Issue 49, pA29 

    The article presents information on a study, according to which, the polyphenol found in turmeric called curcumin play an important role in fight against prostate cancer by restricting the formation of metastases.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics